b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">31026867</PMID>\n        <DateCompleted>\n            <Year>2019</Year>\n            <Month>08</Month>\n            <Day>27</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2019</Year>\n            <Month>08</Month>\n            <Day>27</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1439-4413</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>144</Volume>\n                    <Issue>9</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>05</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Deutsche medizinische Wochenschrift (1946)</Title>\n                <ISOAbbreviation>Dtsch. Med. Wochenschr.</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>[Current Recommendations for Diagnostics in Giant Cell Arteritis].</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>587-594</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1055/a-0831-0812</ELocationID>\n            <Abstract>\n                <AbstractText>In Giant Cell Arteritis (GCA), a timely diagnosis is required to avoid severe complications such as blindness or structural vascular damage. The heterogeneous symptoms are mainly due to local and systemic inflammatory processes. Diagnostics are based on increased inflammation parameters in the laboratory, imaging, in which color-coded duplex sonography (FKDS), high-resolution magnetic resonance imaging (MRI), computer tomography (CT) or CT angiography (CTA) and <sup>18</sup>F fluorodeoxyglucose-positron emission tomography with CT (FDG-PET-CT) have become established, as well as histopathological findings in temporal artery biopsy.</AbstractText>\n                <CopyrightInformation>\xc2\xa9\xc2\xa0Georg Thieme Verlag KG Stuttgart \xc2\xb7 New York.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Bley</LastName>\n                    <ForeName>Thorsten</ForeName>\n                    <Initials>T</Initials>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Z\xc3\xa4nker</LastName>\n                    <ForeName>Michael</ForeName>\n                    <Initials>M</Initials>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Dechant</LastName>\n                    <ForeName>Claudia</ForeName>\n                    <Initials>C</Initials>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Venhoff</LastName>\n                    <ForeName>Nils</ForeName>\n                    <Initials>N</Initials>\n                </Author>\n            </AuthorList>\n            <Language>ger</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <VernacularTitle>Aktuelle Empfehlungen zur Diagnostik der Riesenzellarteriitis.</VernacularTitle>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>04</Month>\n                <Day>26</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Germany</Country>\n            <MedlineTA>Dtsch Med Wochenschr</MedlineTA>\n            <NlmUniqueID>0006723</NlmUniqueID>\n            <ISSNLinking>0012-0472</ISSNLinking>\n        </MedlineJournalInfo>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D013700" MajorTopicYN="N">Giant Cell Arteritis</DescriptorName>\n                <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>\n                <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D017410" MajorTopicYN="N">Practice Guidelines as Topic</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <CoiStatement>Alle Autoren sind Mitglieder des GCA-Experten-Board von Roche/Chugai.TB: Forschungsf\xc3\xb6rderung durch die Deutsche Forschungsgemeinschaft, Mitglied Advisory Board/Beratert\xc3\xa4tigkeit: Siemens Healthineers, Vortragst\xc3\xa4tigkeit: Guerbet, HeartFlow, Fa.\xc2\xa0Roche/Chugai, Siemens.MZ: T\xc3\xa4tigkeit in wissenschaftlichen Advisory Boards der Firmen Roche, MSD und Celgene sowie Vortragshonorare von Roche, MSD und Celgene.CD: Vortragshonorare der Roche Pharma AG, AbbVie, Novartis, medac, Boehringer Ingehlheim, Pfizer, Actelion.NV: Vortrags-/Beratert\xc3\xa4tigkeiten: Fa. Roche, Fa. Chugai, Bristol-Myers-Squibb, Pfizer, Novartis, AbbVie, UCB, Celgene, Medac.</CoiStatement>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>4</Month>\n                <Day>27</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>4</Month>\n                <Day>27</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>8</Month>\n                <Day>28</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31026867</ArticleId>\n            <ArticleId IdType="doi">10.1055/a-0831-0812</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'